Concepedia

Argun Akçakanat

AA

Statistics

Publications

40

Citations

4K

H-Index

30

Active since

2004

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Society of Surgical Oncology

Harvard University

Jackson Laboratory

National Cancer Institute

Argun Akçakanat is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and radiation oncology.

ORCID

Top concepts

Publications per year

2004–2024

40

Publications

40

PD-L1 Expression in Triple-Negative Breast Cancer

Elizabeth A. Mittendorf, Anne V. Philips, Funda Meric‐Bernstam et al. · Cancer Immunology Research · 2014 · 1.4K citations · Full text

, , +14

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

Yan Xing, Nancy U. Lin, Matthew Maurer et al. · Breast Cancer Research · 2019 · 225 citations · Full text

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Funda Meric‐Bernstam, Argun Akçakanat, Huiqin Chen et al. · Clinical Cancer Research · 2012 · 207 citations · Full text

Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer

Takafumi Sangai, Argun Akçakanat, Huiqin Chen et al. · Clinical Cancer Research · 2012 · 157 citations

Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors

Amy C. Moreno, Argun Akçakanat, Mark F. Munsell et al. · Endocrine Related Cancer · 2008 · 146 citations · Full text

, , +16

1–5 of 40